The global burden of chromoblastomycosis.

<h4>Background</h4>Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, includ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel Wagner C L Santos, Conceição de Maria Pedrozo E Silva de Azevedo, Vania Aparecida Vicente, Flávio Queiroz-Telles, Anderson Messias Rodrigues, G Sybren de Hoog, David W Denning, Arnaldo Lopes Colombo
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/b4f8cda1a03340b9ab69f1d66d7581e3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b4f8cda1a03340b9ab69f1d66d7581e3
record_format dspace
spelling oai:doaj.org-article:b4f8cda1a03340b9ab69f1d66d7581e32021-12-02T20:23:40ZThe global burden of chromoblastomycosis.1935-27271935-273510.1371/journal.pntd.0009611https://doaj.org/article/b4f8cda1a03340b9ab69f1d66d7581e32021-08-01T00:00:00Zhttps://doi.org/10.1371/journal.pntd.0009611https://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.<h4>Methods and findings</h4>In order to estimate the global burden of CBM, we retrospectively reviewed the published literature from 1914 to 2020. Over the 106-year period, a total of 7,740 patients with CBM were identified on all continents except Antarctica. Most of the cases were reported from South America (2,619 cases), followed by Africa (1,875 cases), Central America and Mexico (1,628 cases), Asia (1,390 cases), Oceania (168 cases), Europe (35 cases), and USA and Canada (25 cases). We described 4,022 (81.7%) male and 896 (18.3%) female patients, with the median age of 52.5 years. The average time between the onset of the first lesion and CBM diagnosis was 9.2 years (range between 1 month to 50 years). The main sites involved were the lower limbs (56.7%), followed by the upper limbs (19.9%), head and neck (2.9%), and trunk (2.4%). Itching and pain were reported by 21.5% and 11%, respectively. Malignant transformation was described in 22 cases. A total of 3,817 fungal isolates were cultured, being 3,089 (80.9%) Fonsecaea spp., 552 (14.5%) Cladophialophora spp., and 56 Phialophora spp. (1.5%).<h4>Conclusions and significance</h4>This review represents our current knowledge on the burden of CBM world-wide. The global incidence remains unclear and local epidemiological studies are required to improve these data, especially in Africa, Asia, and Latin America. The recognition of CBM as NTD emphasizes the need for public health efforts to promote support for all local governments interested in developing specific policies and actions for preventing, diagnosing and assisting patients.Daniel Wagner C L SantosConceição de Maria Pedrozo E Silva de AzevedoVania Aparecida VicenteFlávio Queiroz-TellesAnderson Messias RodriguesG Sybren de HoogDavid W DenningArnaldo Lopes ColomboPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 8, p e0009611 (2021)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Daniel Wagner C L Santos
Conceição de Maria Pedrozo E Silva de Azevedo
Vania Aparecida Vicente
Flávio Queiroz-Telles
Anderson Messias Rodrigues
G Sybren de Hoog
David W Denning
Arnaldo Lopes Colombo
The global burden of chromoblastomycosis.
description <h4>Background</h4>Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.<h4>Methods and findings</h4>In order to estimate the global burden of CBM, we retrospectively reviewed the published literature from 1914 to 2020. Over the 106-year period, a total of 7,740 patients with CBM were identified on all continents except Antarctica. Most of the cases were reported from South America (2,619 cases), followed by Africa (1,875 cases), Central America and Mexico (1,628 cases), Asia (1,390 cases), Oceania (168 cases), Europe (35 cases), and USA and Canada (25 cases). We described 4,022 (81.7%) male and 896 (18.3%) female patients, with the median age of 52.5 years. The average time between the onset of the first lesion and CBM diagnosis was 9.2 years (range between 1 month to 50 years). The main sites involved were the lower limbs (56.7%), followed by the upper limbs (19.9%), head and neck (2.9%), and trunk (2.4%). Itching and pain were reported by 21.5% and 11%, respectively. Malignant transformation was described in 22 cases. A total of 3,817 fungal isolates were cultured, being 3,089 (80.9%) Fonsecaea spp., 552 (14.5%) Cladophialophora spp., and 56 Phialophora spp. (1.5%).<h4>Conclusions and significance</h4>This review represents our current knowledge on the burden of CBM world-wide. The global incidence remains unclear and local epidemiological studies are required to improve these data, especially in Africa, Asia, and Latin America. The recognition of CBM as NTD emphasizes the need for public health efforts to promote support for all local governments interested in developing specific policies and actions for preventing, diagnosing and assisting patients.
format article
author Daniel Wagner C L Santos
Conceição de Maria Pedrozo E Silva de Azevedo
Vania Aparecida Vicente
Flávio Queiroz-Telles
Anderson Messias Rodrigues
G Sybren de Hoog
David W Denning
Arnaldo Lopes Colombo
author_facet Daniel Wagner C L Santos
Conceição de Maria Pedrozo E Silva de Azevedo
Vania Aparecida Vicente
Flávio Queiroz-Telles
Anderson Messias Rodrigues
G Sybren de Hoog
David W Denning
Arnaldo Lopes Colombo
author_sort Daniel Wagner C L Santos
title The global burden of chromoblastomycosis.
title_short The global burden of chromoblastomycosis.
title_full The global burden of chromoblastomycosis.
title_fullStr The global burden of chromoblastomycosis.
title_full_unstemmed The global burden of chromoblastomycosis.
title_sort global burden of chromoblastomycosis.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/b4f8cda1a03340b9ab69f1d66d7581e3
work_keys_str_mv AT danielwagnerclsantos theglobalburdenofchromoblastomycosis
AT conceicaodemariapedrozoesilvadeazevedo theglobalburdenofchromoblastomycosis
AT vaniaaparecidavicente theglobalburdenofchromoblastomycosis
AT flavioqueiroztelles theglobalburdenofchromoblastomycosis
AT andersonmessiasrodrigues theglobalburdenofchromoblastomycosis
AT gsybrendehoog theglobalburdenofchromoblastomycosis
AT davidwdenning theglobalburdenofchromoblastomycosis
AT arnaldolopescolombo theglobalburdenofchromoblastomycosis
AT danielwagnerclsantos globalburdenofchromoblastomycosis
AT conceicaodemariapedrozoesilvadeazevedo globalburdenofchromoblastomycosis
AT vaniaaparecidavicente globalburdenofchromoblastomycosis
AT flavioqueiroztelles globalburdenofchromoblastomycosis
AT andersonmessiasrodrigues globalburdenofchromoblastomycosis
AT gsybrendehoog globalburdenofchromoblastomycosis
AT davidwdenning globalburdenofchromoblastomycosis
AT arnaldolopescolombo globalburdenofchromoblastomycosis
_version_ 1718374126243020800